Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Drug Shortage Rules Surface In Latest FDA Regulatory Agenda

Jan 07 2013

• By Cathy Dombrowski

Related Content

Central IRBs, Data Security Standards Feature In Overhaul Of "Common Rule"

Aug 01 2011

FDA Cloak And Dagger: GMP "Intelligence" Sought As Part Of Globalization Plan

Mar 15 2011

Medicaid Rebate Extension To Territories Operationally, Legally Questionable, Manufacturers Say

Apr 04 2012

FDA Shortage Notification Mandate May Not Extend To Biologics

Dec 24 2012

FDA’s Rulemaking To-Do List Includes Clarifying Citizen Petitions And Orphan Drug Designations

Feb 06 2012

Foreign Regulatory Systems Can Be Strengthened By Receiving FDA Inspection Data, IOM Says

Apr 09 2012

FDA And EMA Revising GMP Rules To Address Supply Chain Deficiencies

Aug 02 2010

FDA Combination Products Office Finalizing Manufacturing, Adverse Event Rules

Apr 25 2011

Combo Product Firms Want Simpler Adverse Event Reporting Structure

Feb 01 2010

Fiscal Cliff Legislation Adjusts ESRD Payment Bundle To Help Offset Doc Fix

Jan 02 2013

Additional Topics

United States Regulation BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window